High-throughput biochemical analysis of in vivo location data reveals novel distinct classes of POU5F1(Oct4)/DNA complexes.

Genome Research
Dean TantinWilliam G Fairbrother

Abstract

The transcription factor POU5F1 is a key regulator of embryonic stem (ES) cell pluripotency and a known oncoprotein. We have developed a novel high-throughput binding assay called MEGAshift (microarray evaluation of genomic aptamers by shift) that we use to pinpoint the exact location, affinity, and stoichiometry of the DNA-protein complexes identified by chromatin immunoprecipitation studies. We consider all genomic regions identified as POU5F1-ChIP-enriched in both human and mouse. Compared with regions that are ChIP-enriched in a single species, we find these regions more likely to be near actively transcribed genes in ES cells. We resynthesize these genomic regions as a pool of tiled 35-mers. This oligonucleotide pool is then assayed for binding to recombinant POU5F1 by gel shift. The degree of binding for each oligonucleotide is accurately measured on a custom oligonucleotide microarray. We explore the relationship between experimentally determined and computationally predicted binding strengths, find many novel functional combinations of POU5F1 half sites, and demonstrate efficient motif discovery by incorporating binding information into a motif finding algorithm. In addition to further refining location studies for tran...Continue Reading

References

Jun 5, 2002·Genome Research·W James KentDavid Haussler
Jan 17, 2003·Cell Research·Guang Jin PanDuanqing Pei
Mar 5, 2003·Biochemical and Biophysical Research Communications·Masazumi NishimotoAkihiko Okuda
Dec 12, 2003·Cancer Cell·Sharon GidekelEli Pikarsky
May 8, 2004·Nature Reviews. Genetics·Wyeth W Wasserman, Albin Sandelin
Oct 16, 2004·EMBO Reports·James KehlerAlexey Tomilin
Apr 30, 2005·The Journal of Biological Chemistry·David J RoddaPaul Robson
Sep 13, 2005·Cell·Laurie A BoyerRichard A Young
Jan 6, 2007·International Journal of Cancer. Journal International Du Cancer·Yaser AtlasiAhmad-Reza Bahrami
Jun 2, 2007·Science·David S JohnsonBarbara Wold

❮ Previous
Next ❯

Citations

Sep 28, 2010·Bioinformatics·Mike J MasonQing Zhou
Sep 11, 2009·DNA Research : an International Journal for Rapid Publication of Reports on Genes and Genomes·Alexei A Sharov, Minoru S H Ko
Apr 30, 2011·Genome Research·Luciana FerrarisWilliam G Fairbrother
Feb 9, 2010·American Journal of Physiology. Lung Cellular and Molecular Physiology·Amy L FirthJason X-J Yuan
Sep 6, 2012·Development·Mamiko YajimaGary M Wessel
Aug 25, 2012·Yi chuan = Hereditas·Guang-Ming Gu, Jin-Ke Wang
Nov 19, 2013·Nucleic Acids Research·Trevor Siggers, Raluca Gordân
Sep 8, 2009·Trends in Biochemical Sciences·Jinsuk KangDean Tantin
Apr 6, 2016·Biochimica Et Biophysica Acta·Xi Qian, Feng-Qi Zhao
Feb 16, 2016·Biochimica Et Biophysica Acta·Karina Vázquez-Arreguín, Dean Tantin
Aug 19, 2014·Trends in Biochemical Sciences·Matthew SlatteryRemo Rohs
Mar 22, 2014·Frontiers in Oncology·Jennifer R RibeiroRichard N Freiman
Nov 29, 2014·Briefings in Functional Genomics·Kellen K AndrilenasTrevor Siggers
Jul 28, 2016·Computational and Structural Biotechnology Journal·Elisabetta LevatiBarbara Montanini
Jul 16, 2010·Nature Reviews. Genetics·Roger P AlexanderMark B Gerstein
Feb 23, 2010·Molecular BioSystems·Jovan Simicevic, Bart Deplancke
Jun 8, 2017·Nucleic Acids Research·Jaime Abraham Castro-MondragonJacques van Helden

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.